YD Bio Stock (NASDAQ:YDES)
Previous Close
$11.42
52W Range
$5.30 - $25.00
50D Avg
$11.45
200D Avg
$14.07
Market Cap
$798.30M
Avg Vol (3M)
$79.64K
Beta
0.11
Div Yield
-
YDES Company Profile
Breeze Holdings Acquisition Corp. operates as a clinical-stage biopharmaceutical company focuses on cancer prevention medical diagnostics and the development of exosome-based therapeutics with the potential to transform the treatment of a diseases with unmet medical need. The company is based in Taipei, Taiwan.